{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:12:26Z","timestamp":1782846746559,"version":"3.54.5"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009518","name":"Tokyo University of Agriculture and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009518","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12012-026-10126-7","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T02:21:44Z","timestamp":1779848504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Potential Protective Effects of Resveratrol Against Cabazitaxel-Induced Oxidative Stress and Cardiotoxicity in Rats"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5660-5979","authenticated-orcid":false,"given":"Hadeer","family":"Khaled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elfadadny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mandour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryou","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"issue":"41","key":"10126_CR1","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon, A. R., L\u00f3pez-Fern\u00e1ndez, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., & Cosyns, B. (2022). ESC scientific document group. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). European Heart Journal, 43(41), 4229\u20134361.","journal-title":"European Heart Journal"},{"key":"10126_CR2","doi-asserted-by":"crossref","unstructured":"Aziz, T. A. (2021). Cardioprotective effect of quercetin and sitagliptin in doxorubicin-induced cardiac toxicity in rats. Cancer Management and Research, 2349\u20132357.","DOI":"10.2147\/CMAR.S300495"},{"key":"10126_CR3","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.2459\/JCM.0000000000000382","volume":"17","author":"C Cadeddu","year":"2016","unstructured":"Cadeddu, C., Mercurio, V., Spallarossa, P., Nodari, S., Triggiani, M., Monte, I., & Tocchetti, C. G. (2016). Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies. Journal of Cardiovascular Medicine, 17, e64\u2013e75.","journal-title":"Journal of Cardiovascular Medicine"},{"issue":"15","key":"10126_CR4","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3390\/cancers15153969","volume":"15","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Guercio, B. J., & Sahasrabudhe, D. (2023). Current trends in chemotherapy in the treatment of metastatic prostate cancer. Cancers, 15(15), 3969.","journal-title":"Cancers"},{"issue":"9747","key":"10126_CR5","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","volume":"376","author":"JS De Bono","year":"2010","unstructured":"De Bono, J. S., Oudard, S., Ozguroglu, M., Hansen, S., Machiels, J. P., Kocak, I., & Shen, L. (2010). Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial. The Lancet, 376(9747), 1147\u20131154.","journal-title":"The Lancet"},{"issue":"6","key":"10126_CR6","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2217\/fon.13.256","volume":"10","author":"S Bracarda","year":"2014","unstructured":"Bracarda, S., Gernone, A., Gasparro, D., Marchetti, P., Ronzoni, M., Bortolus, R., Fratino, L., Basso, U., Mazzanti, R., Messina, C., Tucci, M., Boccardo, F., Carten\u00ec, G., Pinto, C., Fornarini, G., Mattioli, R., Procopio, G., Chiuri, V., Scotto, T., \u2026 Di Lorenzo, G. (2014). Real-world cabazitaxel safety: The Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncology, 10(6), 975\u2013983. https:\/\/doi.org\/10.2217\/fon.13.256","journal-title":"Future Oncology"},{"issue":"7","key":"10126_CR7","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1684\/bdc.2012.1608","volume":"99","author":"D Pouessel","year":"2012","unstructured":"Pouessel, D., Oudard, S., Gravis, G., Priou, F., Shen, L., & Culine, S. (2012). Cabazitaxel dans le cancer de la prostate m\u00e9tastatique r\u00e9sistant \u00e0 la castration ayant progress\u00e9 pendant ou apr\u00e8s traitement par doc\u00e9taxel\u202f: l\u2019exp\u00e9rience fran\u00e7aise de l\u2019essai TROPIC. Bulletin du Cancer, 99(7), 731\u2013741.","journal-title":"Bulletin du Cancer"},{"key":"10126_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jns.2015.11.033","volume":"360","author":"E Karavelioglu","year":"2016","unstructured":"Karavelioglu, E., Gonul, Y., Aksit, H., Boyaci, M. G., Karademir, M., Simsek, N., Guven, M., Atalay, T., & Rakip, U. (2016). Cabazitaxel causes a dose-dependent central nervous system toxicity in rats. Journal of the Neurological Sciences, 360, 66\u201371. https:\/\/doi.org\/10.1016\/j.jns.2015.11.033","journal-title":"Journal of the Neurological Sciences"},{"key":"10126_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113903","volume":"156","author":"Y Chen","year":"2022","unstructured":"Chen, Y., Shi, S., & Dai, Y. (2022). Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy. Biomedicine & Pharmacotherapy, 156, Article 113903.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"8","key":"10126_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/jcdd9080259","volume":"9","author":"C Kourek","year":"2022","unstructured":"Kourek, C., Touloupaki, M., Rempakos, A., Loritis, K., Tsougkos, E., Paraskevaidis, I., & Briasoulis, A. (2022). Cardioprotective strategies from cardiotoxicity in cancer patients: A comprehensive review. Journal of Cardiovascular Development and Disease, 9(8), 259.","journal-title":"Journal of Cardiovascular Development and Disease"},{"issue":"6","key":"10126_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062084","volume":"21","author":"A Shaito","year":"2020","unstructured":"Shaito, A., Posadino, A. M., Younes, N., Hasan, H., Halabi, S., Alhababi, D., Al-Mohannadi, A., Abdel-Rahman, W. M., Eid, A. H., Pintus, G., & Nasrallah, G. K. (2020). Potential adverse effects of resveratrol: A literature review. International Journal of Molecular Sciences, 21(6), Article 2084.","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10126_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/ajh.2009.228","volume":"23","author":"SJ Thandapilly","year":"2010","unstructured":"Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., & Netticadan, T. (2010). Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. American Journal of Hypertension, 23(2), 192\u2013196.","journal-title":"American Journal of Hypertension"},{"issue":"12","key":"10126_CR13","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/j.2042-7158.2010.01197.x","volume":"62","author":"HZ Toklu","year":"2010","unstructured":"Toklu, H. Z., \u015eehirli, \u00d6., Er\u015fahin, M., S\u00fcleymano\u011flu, S., Yi\u011finer, \u00d6., Emekli-Alturfan, E., Yarat, A., Ye\u011fen, B. \u00c7., & \u015eener, G. (2010). Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. Journal of Pharmacy and Pharmacology, 62(12), 1784\u20131793.","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"8","key":"10126_CR14","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/10408398.2017.1400517","volume":"59","author":"RF Pastor","year":"2019","unstructured":"Pastor, R. F., Restani, P., Di Lorenzo, C., Orgiu, F., Teissedre, P. L., Stockley, C., & Gargantini, R. (2019). Resveratrol, human health and winemaking perspectives. Critical reviews in food science and nutrition, 59(8), 1237\u20131255.","journal-title":"Critical reviews in food science and nutrition"},{"key":"10126_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145968","volume":"808","author":"T Li","year":"2022","unstructured":"Li, T., Tan, Y., Ouyang, S., He, J., & Liu, L. (2022). Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene, 808, Article 145968.","journal-title":"Gene"},{"issue":"13","key":"10126_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137477","volume":"25","author":"R Vitale","year":"2024","unstructured":"Vitale, R., Marzocco, S., & Popolo, A. (2024). Role of oxidative stress and inflammation in doxorubicin-induced cardiotoxicity: A brief account. International Journal of Molecular Sciences, 25(13), Article 7477.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10126_CR17","volume":"2019","author":"S Steven","year":"2019","unstructured":"Steven, S., Frenis, K., Oelze, M., Kalinovic, S., Kuntic, M., Bayo Jimenez, M. T., Vujacic-Mirski, K., Helmst\u00e4dter, J., Kr\u00f6ller-Sch\u00f6n, S., Daiber, A., & M\u00fcnzel, T. (2019). Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease. Oxidative Medicine and Cellular Longevity, 2019(1), Article 7092151.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10126_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2006.07.001","author":"M Valko","year":"2007","unstructured":"Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology. https:\/\/doi.org\/10.1016\/j.biocel.2006.07.001","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10126_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2022.03.001","volume":"354","author":"Y Hitomi","year":"2022","unstructured":"Hitomi, Y., Masaki, N., Ishinoda, Y., Ido, Y., Iwashita, M., Yumita, Y., & Adachi, T. (2022). Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality. International Journal of Cardiology, 354, 43\u201347. https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.001","journal-title":"International Journal of Cardiology"},{"issue":"5","key":"10126_CR20","first-page":"855","volume":"19","author":"K Dohi","year":"2005","unstructured":"Dohi, K., Satoh, K., Ohtaki, H., Shioda, S., Miyake, Y., Shindo, M., & Aruga, T. (2005). Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging. In Vivo, 19(5), 855\u2013860.","journal-title":"In Vivo"},{"issue":"1","key":"10126_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1439-0442.2007.00911.x","volume":"54","author":"CS Hetyey","year":"2007","unstructured":"Hetyey, C. S., Manczur, F., Dud\u00e1s-Gy\u00f6rki, Z., Reiczigel, J., Ribiczey, P., Vajdovich, P., & V\u00f6r\u00f6s, K. (2007). Plasma antioxidant capacity in dogs with naturally occurring heart diseases. Journal of Veterinary Medicine Series A, 54(1), 36\u201339.","journal-title":"Journal of Veterinary Medicine Series A"},{"issue":"50","key":"10126_CR22","doi-asserted-by":"publisher","first-page":"87675","DOI":"10.18632\/oncotarget.21147","volume":"8","author":"T Kosaka","year":"2017","unstructured":"Kosaka, T., Hongo, H., Miyazaki, Y., Nishimoto, K., Miyajima, A., & Oya, M. (2017). Reactive oxygen species induction by cabazitaxel through inhibiting Sestrin-3 in castration resistant prostate cancer. Oncotarget, 8(50), 87675.","journal-title":"Oncotarget"},{"issue":"5","key":"10126_CR23","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/jvim.15562","volume":"33","author":"LC Visser","year":"2019","unstructured":"Visser, L. C., Ciccozzi, M. M., Sintov, D. J., & Sharpe, A. N. (2019). Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability. Journal of Veterinary Internal Medicine, 33(5), 1909\u20131920.","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"3","key":"10126_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","volume":"55","author":"D Cardinale","year":"2010","unstructured":"Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., & Cipolla, C. M. (2010). Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. Journal of the American College of Cardiology, 55(3), 213\u2013220.","journal-title":"Journal of the American College of Cardiology"},{"key":"10126_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.rvsc.2016.02.001","volume":"105","author":"J Gallay-Lepoutre","year":"2016","unstructured":"Gallay-Lepoutre, J., B\u00e9langer, M. C., & Nadeau, M. E. (2016). Prospective evaluation of Doppler echocardiography, tissue Doppler imaging and biomarkers measurement for the detection of doxorubicin-induced cardiotoxicity in dogs: A pilot study. Research in veterinary science, 105, 153\u2013159.","journal-title":"Research in veterinary science"},{"issue":"18","key":"10126_CR26","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1161\/01.CIR.99.18.2367","volume":"99","author":"I Hashimoto","year":"1999","unstructured":"Hashimoto, I., Ichida, F., Miura, M., Okabe, T., Kanegane, H., Uese, K., & Miyawaki, T. (1999). Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy. Circulation, 99(18), 2367\u20132370.","journal-title":"Circulation"},{"issue":"2","key":"10126_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.euje.2005.04.009","volume":"7","author":"S Tassan-Mangina","year":"2006","unstructured":"Tassan-Mangina, S., Codorean, D., Metivier, M., Costa, B., Himberlin, C., Jouannaud, C., & Nazeyrollas, P. (2006). Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: Early and late alterations of left ventricular function during a prospective study. European Journal of Echocardiography, 7(2), 141\u2013146.","journal-title":"European Journal of Echocardiography"},{"issue":"4","key":"10126_CR28","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/ani11041122","volume":"11","author":"K Matsuura","year":"2021","unstructured":"Matsuura, K., Shiraishi, K., Mandour, A. S., Sato, K., Shimada, K., Goya, S., & Uemura, A. (2021). The utility of intraventricular pressure gradient for early detection of chemotherapy-induced subclinical cardiac dysfunction in dogs. Animals, 11(4), 1122.","journal-title":"Animals"},{"key":"10126_CR29","doi-asserted-by":"crossref","unstructured":"Little, W. C. (2005). Diastolic dysfunction beyond distensibility: Adverse effects of ventricular dilatation. Circulation. Lippincott Williams & Wilkins.","DOI":"10.1161\/CIRCULATIONAHA.105.578161"},{"key":"10126_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1182628","volume":"10","author":"A Farag","year":"2023","unstructured":"Farag, A., Mandour, A. S., Kaneda, M., Elfadadny, A., Elhaieg, A., Shimada, K., & Tanaka, R. (2023). Effect of trehalose on heart functions in rats model after myocardial infarction: Assessment of novel intraventricular pressure and heart rate variability. Frontiers in Cardiovascular Medicine, 10, Article 1182628.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"Suppl 1","key":"10126_CR31","doi-asserted-by":"publisher","first-page":"S314","DOI":"10.4103\/jcrt.jcrt_774_21","volume":"19","author":"A Bucak","year":"2023","unstructured":"Bucak, A., \u00d6zdemir, \u00c7., K\u0131nar, A., Ulu, \u015e., Kuzu, S., G\u00fcnebakan, \u00c7., & Kahveci, O. K. (2023). Cabazitaxel\u2019s ototoxicity: An animal study and histopathologic research. Journal of Cancer Research and Therapeutics, 19(Suppl 1), S314\u2013S317.","journal-title":"Journal of Cancer Research and Therapeutics"},{"issue":"2","key":"10126_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/10520295.2021.1918766","volume":"97","author":"N Bostanc\u0131eri","year":"2022","unstructured":"Bostanc\u0131eri, N., Elbe, H., E\u015frefo\u011flu, M., & Vard\u0131, N. (2022). Cardioprotective potential of melatonin, quercetin and resveratrol in an experimental model of diabetes. Biotechnic & Histochemistry, 97(2), 152\u2013157.","journal-title":"Biotechnic & Histochemistry"},{"issue":"3","key":"10126_CR33","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.3892\/mmr.2014.2384","volume":"10","author":"SE Al-Harthi","year":"2014","unstructured":"Al-Harthi, S. E., Alarabi, O. M., Ramadan, W. S., Alaama, M. N., Al-Kreathy, H. M., Damanhouri, Z. A., & Osman, A. M. (2014). Amelioration of doxorubicin-induced cardiotoxicity by resveratrol. Molecular medicine reports, 10(3), 1455\u20131460.","journal-title":"Molecular medicine reports"},{"issue":"12","key":"10126_CR34","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/j.2042-7158.2010.01197.x","volume":"62","author":"HZ Toklu","year":"2010","unstructured":"Toklu, H. Z., \u015eehirli, \u00d6., Er\u015fahin, M., S\u00fcleymano\u011flu, S., Yi\u011finer, \u00d6., Emekli-Alturfan, E., Sehirli, O., Yarat, A., Ye\u011fen, B. \u00c7., Sener, G., & \u015eener, G. (2010). Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats. Journal of Pharmacy and Pharmacology, 62(12), 1784\u20131793.","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"8","key":"10126_CR35","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1017\/S1751731113000396","volume":"7","author":"A Abuelo","year":"2013","unstructured":"Abuelo, A., Hern\u00e1ndez, J., Benedito, J. L., & Castillo, C. (2013). Oxidative stress index (OSi) as a new tool to assess redox status in dairy cattle during the transition period. Animal, 7(8), 1374\u20131378. https:\/\/doi.org\/10.1017\/S1751731113000396","journal-title":"Animal"},{"issue":"7","key":"10126_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.echo.2004.04.011","volume":"17","author":"J Rychik","year":"2004","unstructured":"Rychik, J., Ayres, N., Cuneo, B., Gotteiner, N., Hornberger, L., Spevak, P. J., & Van Der Veld, M. (2004). American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. Journal of the American Society of Echocardiography, 17(7), 803\u2013810.","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"1","key":"10126_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/cvr\/cvaa110","volume":"117","author":"S Zacchigna","year":"2021","unstructured":"Zacchigna, S., Paldino, A., Falc\u00e3o-Pires, I., P Daskalopoulos, E., Dal Ferro, M., Vodret, S., & P Louren\u00e7o, A. (2021). Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: A position paper of the ESC Working Group on Myocardial Function. Cardiovascular Research, 117(1), 43\u201359.","journal-title":"Cardiovascular Research"},{"issue":"8","key":"10126_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081403","volume":"11","author":"A Yairo","year":"2021","unstructured":"Yairo, A., Mandour, A. S., Matsuura, K., Yoshida, T., Ma, D., Kitpipatkun, P., Kato, K., Cheng, C. J., El-Husseiny, H. M., Shimada, K., Hamabe, L., Uemura, A., Takahashi, K., Tanaka, R., & Tanaka, T. (2021). Effect of loading changes on the intraventricular pressure measured by color M-mode echocardiography in rats. Diagnostics, 11(8), Article 1403.","journal-title":"Diagnostics"},{"issue":"9","key":"10126_CR39","first-page":"861","volume":"5","author":"T Ohara","year":"2012","unstructured":"Ohara, T., Niebel, C. L., Stewart, K. C., Charonko, J. J., Pu, M., Vlachos, P. P., & Little, W. C. (2012). Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: Evaluation by color M-mode echocardiography. JACC: Cardiovascular Imaging, 5(9), 861\u2013870.","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"2","key":"10126_CR40","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00380-018-1239-9","volume":"34","author":"K Takahashi","year":"2019","unstructured":"Takahashi, K., Nii, M., Takigiku, K., Toyono, M., Iwashima, S., Inoue, N., & Yamada, M. (2019). Development of suction force during early diastole from the left atrium to the left ventricle in infants, children, and adolescents. Heart and Vessels, 34(2), 296\u2013306.","journal-title":"Heart and Vessels"},{"issue":"3","key":"10126_CR41","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10396-020-01021-x","volume":"47","author":"P Kitpipatkun","year":"2020","unstructured":"Kitpipatkun, P., Matsuura, K., Shimada, K., Uemura, A., Goya, S., Yoshida, T., & Tanaka, R. (2020). Key factors of diastolic dysfunction and abnormal left ventricular relaxation in diabetic rats. Journal of Medical Ultrasonics, 47(3), 347\u2013356.","journal-title":"Journal of Medical Ultrasonics"},{"issue":"4","key":"10126_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1742271X20987584","volume":"29","author":"D Ma","year":"2021","unstructured":"Ma, D., Mandour, A. S., Yoshida, T., Matsuura, K., Shimada, K., Kitpipatkun, P., Uemura, A., Ifuku, M., Takahashi, K., & Tanaka, R. (2021). Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker. Ultrasound (Leeds, England), 29(4), 229\u2013240.","journal-title":"Ultrasound (Leeds, England)"},{"key":"10126_CR43","doi-asserted-by":"crossref","unstructured":"Doggett, T. M., Tur, J. J., Alves, N. G., Yuan, S. Y., Tipparaju, S. M., & Breslin, J. W. (2018). Assessment of cardiovascular function and microvascular permeability in a conscious rat model of alcohol intoxication combined with hemorrhagic shock and resuscitation. Traumatic and Ischemic Injury: Methods and Protocols, 61\u201381.","DOI":"10.1007\/978-1-4939-7526-6_6"},{"issue":"2","key":"10126_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1542-474X.1997.tb00325.x","volume":"2","author":"HC Bazett","year":"1997","unstructured":"Bazett, H. C. (1997). An analysis of the time-relations of electrocardiograms. Annals of Noninvasive Electrocardiology, 2(2), 177\u2013194.","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"1","key":"10126_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1756-8722-7-25","volume":"7","author":"K Shi","year":"2014","unstructured":"Shi, K., Zhao, W., Chen, Y., Ho, W. T., Yang, P., & Zhao, Z. J. (2014). Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice. Journal of Hematology & Oncology, 7(1), 25.","journal-title":"Journal of Hematology & Oncology"},{"issue":"5","key":"10126_CR46","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s13346-018-0562-0","volume":"8","author":"Y Liu","year":"2018","unstructured":"Liu, Y., Xie, B., Li, L., Zhang, X., Zhang, Y., He, H., & Gou, J. (2018). PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: Stability, bioavailability, antitumor efficacy, and toxicity. Drug Delivery and Translational Research, 8(5), 1365\u20131379. https:\/\/doi.org\/10.1007\/s13346-018-0562-0","journal-title":"Drug Delivery and Translational Research"},{"key":"10126_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102656","author":"A Hyldbakk","year":"2023","unstructured":"Hyldbakk, A., Fleten, K. G., Snipstad, S., \u00c5slund, A. K. O., Davies, C., Flatmark, K., & M\u00f8rch, Y. (2023). Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models. Nanomedicine: Nanotechnology, Biology, and Medicine. https:\/\/doi.org\/10.1016\/j.nano.2023.102656","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"issue":"1-2","key":"10126_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijpharm.2017.07.011","volume":"529","author":"X Zhu","year":"2017","unstructured":"Zhu, X., Tsend-Ayush, A., Yuan, Z., Wen, J., Cai, J., Luo, S., & Yao, J. (2017). Glycyrrhetinic acid-modified TPGS polymeric micelles for hepatocellular carcinoma-targeted therapy. International Journal of Pharmaceutics, 529(1-2), 451\u2013464. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.011","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10126_CR49","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13105-014-0339-y","volume":"70","author":"MH Arafa","year":"2014","unstructured":"Arafa, M. H., Mohammad, N. S., Atteia, H. H., & Abd-Elaziz, H. R. (2014). Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. Journal of Physiology and Biochemistry, 70(3), 701\u2013711. https:\/\/doi.org\/10.1007\/s13105-014-0339-y","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"5","key":"10126_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00726-023-03261-w","volume":"55","author":"MI Shosha","year":"2023","unstructured":"Shosha, M. I., El-Ablack, F. Z., & Saad, E. A. (2023). Glycine protects against doxorubicin-induced heart toxicity in mice. Amino Acids, 55(5), 679\u2013693.","journal-title":"Amino Acids"},{"key":"10126_CR51","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/795602","author":"P Angsutararux","year":"2015","unstructured":"Angsutararux, P., Luanpitpong, S., & Issaragrisil, S. (2015). Chemotherapy-induced cardiotoxicity: Overview of the roles of oxidative stress. Oxidative Medicine and Cellular Longevity. https:\/\/doi.org\/10.1155\/2015\/795602","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10126_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081984","author":"M Kopa\u010d","year":"2025","unstructured":"Kopa\u010d, M., Jerin, A., Bohinc, E., & Osredkar, J. (2025). Correlation of oxidative stress biomarkers with activity of pediatric idiopathic nephrotic syndrome. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines13081984","journal-title":"Biomedicines"},{"key":"10126_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71827-9","author":"S Sergazy","year":"2020","unstructured":"Sergazy, S., Shulgau, Z., Fedotovskikh, G., Chulenbayeva, L., Nurgozhina, A., Nurgaziyev, M., & Aljofan, M. (2020). Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-020-71827-9","journal-title":"Scientific Reports"},{"issue":"8","key":"10126_CR54","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1016\/j.clinthera.2015.05.140","volume":"37","author":"Z Shulgau","year":"2015","unstructured":"Shulgau, Z., Gulyayev, A., Yermekbayeva, B., Adilgozhina, G., Tritek, V., & Nurgozhin, T. (2015). Cardioprotective properties of polyphenol concentrate in rat model of Doxorubicin-induced cardiomyopathy. Clinical Therapeutics, 37(8), e46\u2013e47. https:\/\/doi.org\/10.1016\/j.clinthera.2015.05.140","journal-title":"Clinical Therapeutics"},{"key":"10126_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101271","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2021","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9, C., Bellver-Sanchis, A., Izquierdo, V., Corpas, R., Roig-Soriano, J., Chill\u00f3n, M., & Pall\u00e0s, M. (2021). The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer\u2019s disease pathology: From antioxidant to epigenetic therapy. Ageing Research Reviews. https:\/\/doi.org\/10.1016\/j.arr.2021.101271","journal-title":"Ageing Research Reviews"},{"key":"10126_CR56","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.8.5740","author":"KB Harikumar","year":"2008","unstructured":"Harikumar, K. B., & Aggarwal, B. B. (2008). Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle. https:\/\/doi.org\/10.4161\/cc.7.8.5740","journal-title":"Cell Cycle"},{"key":"10126_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10091440","author":"MT Liao","year":"2021","unstructured":"Liao, M. T., Wu, C. C., Wu, S. F. V., Lee, M. C., Hu, W. C., Tsai, K. W., & Lu, K. C. (2021). Resveratrol as an adjunctive therapy for excessive oxidative stress in aging covid-19 patients. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10091440","journal-title":"Antioxidants"},{"issue":"2","key":"10126_CR58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tvjl.2008.09.018","volume":"183","author":"P Celi","year":"2010","unstructured":"Celi, P., Sullivan, M., & Evans, D. (2010). The stability of the reactive oxygen metabolites (d-ROMs) and biological antioxidant potential (BAP) tests on stored horse blood. Veterinary Journal, 183(2), 217\u2013218. https:\/\/doi.org\/10.1016\/j.tvjl.2008.09.018","journal-title":"Veterinary Journal"},{"key":"10126_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrgentox.2017.05.003","volume":"819","author":"S Chinde","year":"2017","unstructured":"Chinde, S., & Grover, P. (2017). Toxicological assessment of nano and micron-sized tungsten oxide after 28 days repeated oral administration to Wistar rats. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 819, 1\u201313. https:\/\/doi.org\/10.1016\/j.mrgentox.2017.05.003","journal-title":"Mutation Research - Genetic Toxicology and Environmental Mutagenesis"},{"issue":"1","key":"10126_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pestbp.2008.09.004","volume":"93","author":"SA Mansour","year":"2009","unstructured":"Mansour, S. A., & Mossa, A. T. H. (2009). Lipid peroxidation and oxidative stress in rat erythrocytes induced by chlorpyrifos and the protective effect of zinc. Pesticide Biochemistry and Physiology, 93(1), 34\u201339. https:\/\/doi.org\/10.1016\/j.pestbp.2008.09.004","journal-title":"Pesticide Biochemistry and Physiology"},{"issue":"3","key":"10126_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics11030141","volume":"11","author":"N Kommineni","year":"2019","unstructured":"Kommineni, N., Mahira, S., Domb, A. J., & Khan, W. (2019). Cabazitaxel-loaded nanocarriers for cancer therapy with reduced side effects. Pharmaceutics, 11(3), 1\u201322. https:\/\/doi.org\/10.3390\/pharmaceutics11030141","journal-title":"Pharmaceutics"},{"issue":"4","key":"10126_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3109\/09537104.2010.550349","volume":"22","author":"J Malinowska","year":"2011","unstructured":"Malinowska, J., & Olas, B. (2011). Response of blood platelets to resveratrol during a model of hyperhomocysteinemia. Platelets, 22(4), 277\u2013283.","journal-title":"Platelets"},{"issue":"5","key":"10126_CR63","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/09537100400020591","volume":"16","author":"B Olas","year":"2005","unstructured":"Olas, B., & Wachowicz, B. (2005). Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets, 16(5), 251\u2013260.","journal-title":"Platelets"},{"key":"10126_CR64","doi-asserted-by":"crossref","unstructured":"Ye, Q., Cheng, J., Ye, M., Liu, D., & Zhang, Y. (2019). Association of pretreatment thrombocytosis with prognosis in ovarian cancer: A systematic review and meta-analysis. Journal of gynecologic oncology, 30(1).","DOI":"10.3802\/jgo.2019.30.e5"},{"key":"10126_CR65","doi-asserted-by":"crossref","unstructured":"Armour, S. M., Baur, J. A., Hsieh, S. N., Land-Bracha, A., Thomas, S. M., & Sinclair, D. A. (2009). Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany NY), 1(6), 515.","DOI":"10.18632\/aging.100056"},{"key":"10126_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2006.00228.x","author":"JH Bauer","year":"2006","unstructured":"Bauer, J. H., & Helfand, S. L. (2006). New tricks of an old molecule: Lifespan regulation by p53. Aging Cell. https:\/\/doi.org\/10.1111\/j.1474-9726.2006.00228.x","journal-title":"Aging Cell"},{"key":"10126_CR67","unstructured":"Fleming, M. D., Law, T., Mannu, F., Kuypers, F. A., Bast, A., Van Der Vijgh, W. J. F., & Brugnara, C. (2004). LUCIA DE FRANCESCHI FRANCO TURRINI MAREK HONCZARENKO KOJIO AYI ALICIA RIVERA. haematologica (Vol. 89)."},{"issue":"20","key":"10126_CR68","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0024-3205(03)00096-1","volume":"72","author":"X Vitrac","year":"2003","unstructured":"Vitrac, X., Desmouli\u00e8re, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., & M\u00e9rillon, J. M. (2003). Distribution of [14 C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences, 72(20), 2219\u20132233. https:\/\/doi.org\/10.1016\/S0024-3205(03)00096-1","journal-title":"Life Sciences"},{"issue":"1","key":"10126_CR69","doi-asserted-by":"publisher","first-page":"118","DOI":"10.35440\/hutfd.1403862","volume":"21","author":"Y G\u00f6k\u00e7e","year":"2024","unstructured":"G\u00f6k\u00e7e, Y., Dan\u0131\u015fman, B., & Cicek, B. (2024). Evaluating the effects of acute and chronic doxorubicin administration on cardiac function through electrocardiographic measurements. Harran \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi, 21(1), 118\u2013122.","journal-title":"Harran \u00dcniversitesi T\u0131p Fak\u00fcltesi Dergisi"},{"issue":"11","key":"10126_CR70","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s12012-021-09685-8","volume":"21","author":"M Rahmanifard","year":"2021","unstructured":"Rahmanifard, M., Vessal, M., Noorafshan, A., Karbalay-Doust, S., & Naseh, M. (2021). The protective effects of coenzyme Q10 and lisinopril against doxorubicin-induced cardiotoxicity in rats: A stereological and electrocardiogram study. Cardiovascular Toxicology, 21(11), 936\u2013946.","journal-title":"Cardiovascular Toxicology"},{"key":"10126_CR71","doi-asserted-by":"crossref","unstructured":"Sheibani, M., Faghir-Ghanesefat, H., Azizi, Y., Mokhtari, T., Yousefi-Manesh, H.,Badkoubeh, R. S., \u2026 Dehpour, A. R. (2021). Anti-inflammatory and antioxidative effects of sumatriptan against doxorubicin-induced cardiotoxicity in rat. Acta Medica Iranica, (7), 406.","DOI":"10.18502\/acta.v59i7.7020"},{"issue":"8","key":"10126_CR72","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1592\/phco.28.8.1059","volume":"28","author":"CE O\u2019Brien","year":"2008","unstructured":"O\u2019Brien, C. E., Harik, N., James, L. P., Seib, P. M., & Stowe, C. D. (2008). Cesium-induced QT\u2010Interval prolongation in an adolescent. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 28(8), 1059\u20131065.","journal-title":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"},{"issue":"6","key":"10126_CR73","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/CIRCRESAHA.115.303633","volume":"118","author":"CG Lenneman","year":"2016","unstructured":"Lenneman, C. G., & Sawyer, D. B. (2016). Cardio-oncology: An update on cardiotoxicity of cancer-related treatment. Circulation Research, 118(6), 1008\u20131020.","journal-title":"Circulation Research"},{"issue":"5","key":"10126_CR74","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11886-017-0846-x","volume":"19","author":"D Jain","year":"2017","unstructured":"Jain, D., Russell, R. R., Schwartz, R. G., Panjrath, G. S., & Aronow, W. (2017). Cardiac complications of cancer therapy: Pathophysiology, identification, prevention, treatment, and future directions. Current Cardiology Reports, 19(5), 36.","journal-title":"Current Cardiology Reports"},{"issue":"2","key":"10126_CR75","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijcard.2013.03.133","volume":"168","author":"MC Todaro","year":"2013","unstructured":"Todaro, M. C., Oreto, L., Qamar, R., Paterick, T. E., Carerj, S., & Khandheria, B. K. (2013). Cardioncology: State of the heart. International Journal of Cardiology, 168(2), 680\u2013687.","journal-title":"International Journal of Cardiology"},{"issue":"4","key":"10126_CR76","first-page":"1132","volume":"11","author":"TW Mudd Jr","year":"2021","unstructured":"Mudd, T. W., Jr., Khalid, M., & Guddati, A. K. (2021). Cardiotoxicity of chemotherapy and targeted agents. American Journal of Cancer Research, 11(4), 1132.","journal-title":"American Journal of Cancer Research"},{"key":"10126_CR77","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.2459\/JCM.0000000000000376","volume":"17","author":"C Madeddu","year":"2016","unstructured":"Madeddu, C., Deidda, M., Piras, A., Cadeddu, C., Demurtas, L., Puzzoni, M., & Mercuro, G. (2016). Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy. Journal of cardiovascular medicine, 17, e12\u2013e18.","journal-title":"Journal of cardiovascular medicine"},{"issue":"2","key":"10126_CR78","doi-asserted-by":"publisher","first-page":"336","DOI":"10.21608\/aps.2025.371857.1220","volume":"9","author":"YM El-Nagar","year":"2025","unstructured":"El-Nagar, Y. M., George, M. Y., El Wakeel, S., & Elsherbiny, D. A. (2025). Paclitaxel-induced cardiotoxicity: Mechanisms, molecular insights, and clinical implications. Archives of Pharmaceutical Sciences Ain Shams University, 9(2), 336\u2013350.","journal-title":"Archives of Pharmaceutical Sciences Ain Shams University"},{"issue":"3","key":"10126_CR79","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMoa1213755","volume":"369","author":"C Parker","year":"2013","unstructured":"Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O\u2019Sullivan, J. M., Foss\u00e5, S. D., & Seke, M. (2013). Alpha emitter radium-223 and survival in metastatic prostate cancer. New England Journal of Medicine, 369(3), 213\u2013223.","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10126_CR80","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00210-023-02382-z","volume":"396","author":"PL Dulf","year":"2023","unstructured":"Dulf, P. L., Mocan, M., Coad\u0103, C. A., Dulf, D. V., Moldovan, R., Baldea, I., & Filip, A. G. (2023). Doxorubicin-induced acute cardiotoxicity is associated with increased oxidative stress, autophagy, and inflammation in a murine model. Naunyn-Schmiedeberg\u2019s Archives of Pharmacology, 396(6), 1105\u20131115. https:\/\/doi.org\/10.1007\/s00210-023-02382-z","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"issue":"10","key":"10126_CR81","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.acvd.2019.06.004","volume":"112","author":"A Altes","year":"2019","unstructured":"Altes, A., Sochala, M., Attias, D., Dreyfus, J., Bohbot, Y., Toledano, M., & Mar\u00e9chaux, S. (2019). Correlates of the ratio of acceleration time to ejection time in patients with aortic stenosis: An echocardiographic and computed tomography study. Archives of Cardiovascular Diseases, 112(10), 567\u2013575. https:\/\/doi.org\/10.1016\/j.acvd.2019.06.004","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10126_CR82","doi-asserted-by":"crossref","unstructured":"Brutsaert, D. L., Sys, S. U., & Antwerp, P. (1997). Review diastolic dysfunction in heart failure. Journal of Cardiac Failure (3).","DOI":"10.1016\/S1071-9164(97)90019-1"},{"issue":"11","key":"10126_CR83","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1136\/hrt.2005.084145","volume":"92","author":"T Weber","year":"2006","unstructured":"Weber, T., Auer, J., O\u2019Rourke, M. F., Punzengruber, C., Kvas, E., & Eber, B. (2006). Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction. Heart, 92(11), 1616\u20131622.","journal-title":"Heart"},{"key":"10126_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116794","author":"L Chen","year":"2024","unstructured":"Chen, L., Sun, X., Wang, Z., Chen, M., He, Y., Zhang, H., & Zheng, L. (2024). Resveratrol protects against doxorubicin-induced cardiotoxicity by attenuating ferroptosis through modulating the MAPK signaling pathway. Toxicology and Applied Pharmacology. https:\/\/doi.org\/10.1016\/j.taap.2023.116794","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10126_CR85","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","volume":"20","author":"C Chen","year":"2019","unstructured":"Chen, C., Zou, L. X., Lin, Q. Y., Yan, X., Bi, H. L., Xie, X., & Li, H. H. (2019). Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biology, 20, 390\u2013401. https:\/\/doi.org\/10.1016\/j.redox.2018.10.021","journal-title":"Redox Biology"},{"issue":"22","key":"10126_CR86","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.3390\/ani14223320","volume":"14","author":"M Hirose","year":"2024","unstructured":"Hirose, M., Watanabe, M., Takeuchi, A., Yokoi, A., Terai, K., Matsuura, K., & Tanaka, R. (2024). Differences in the impact of left ventricular outflow tract obstruction on intraventricular pressure gradient in feline hypertrophic cardiomyopathy. Animals, 14(22), 3320.","journal-title":"Animals"},{"issue":"2","key":"10126_CR87","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00380-018-1239-9","volume":"34","author":"K Takahashi","year":"2019","unstructured":"Takahashi, K., Nii, M., Takigiku, K., Toyono, M., Iwashima, S., Inoue, N., & Yamada, M. (2019). Development of suction force during early diastole from the left atrium to the left ventricle in infants, children, and adolescents. Heart and Vessels, 34(2), 296\u2013306.","journal-title":"Heart and Vessels"},{"issue":"4","key":"10126_CR88","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1742271X20987584","volume":"29","author":"D Ma","year":"2021","unstructured":"Ma, D., Mandour, A. S., Yoshida, T., Matsuura, K., Shimada, K., Kitpipatkun, P., & Tanaka, R. (2021). Intraventricular pressure gradients change during the development of left ventricular hypertrophy: Effect of salvianolic acid B and beta-blocker. Ultrasound, 29(4), 229\u2013240.","journal-title":"Ultrasound"},{"issue":"4","key":"10126_CR89","doi-asserted-by":"publisher","first-page":"H882","DOI":"10.1152\/ajpheart.00686.2018","volume":"316","author":"K Matsuura","year":"2019","unstructured":"Matsuura, K., Shiraishi, K., Sato, K., Shimada, K., Goya, S., Uemura, A., & Tanaka, R. (2019). Left ventricular vortex and intraventricular pressure difference in dogs under various loading conditions. American Journal of Physiology-Heart and Circulatory Physiology, 316(4), H882\u2013H888.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"6","key":"10126_CR90","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00380-018-01332-7","volume":"34","author":"S Shigemitsu","year":"2019","unstructured":"Shigemitsu, S., Takahashi, K., Yazaki, K., Kobayashi, M., Yamada, M., Akimoto, K., & Nii, M. (2019). New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy. Heart and Vessels, 34(6), 992\u20131001.","journal-title":"Heart and Vessels"},{"issue":"22","key":"10126_CR91","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.3390\/ani14223320","volume":"14","author":"M Hirose","year":"2024","unstructured":"Hirose, M., Watanabe, M., Takeuchi, A., Yokoi, A., Terai, K., Matsuura, K., & Tanaka, R. (2024). Differences in the impact of left ventricular outflow tract obstruction on intraventricular pressure gradient in feline hypertrophic cardiomyopathy. Animals, 14(22), 3320.","journal-title":"Animals"},{"issue":"6","key":"10126_CR92","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.yjmcc.2012.03.009","volume":"52","author":"B Fraysse","year":"2012","unstructured":"Fraysse, B., Weinberger, F., Bardswell, S. C., Cuello, F., Vignier, N., Geertz, B., & Carrier, L. (2012). Increased myofilament Ca 2 + sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. Journal of Molecular and Cellular Cardiology, 52(6), 1299\u20131307. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.03.009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"10126_CR93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12012-023-09784-8","volume":"23","author":"SM Satyam","year":"2023","unstructured":"Satyam, S. M., Bairy, L. K., Shetty, P., Sainath, P., Bharati, S., Ahmed, A. Z., & Ashwal, A. J. (2023). Metformin and dapagliflozin attenuate doxorubicin-induced acute cardiotoxicity in wistar rats: An electrocardiographic, biochemical, and histopathological approach. Cardiovascular Toxicology, 23(2), 107\u2013119. https:\/\/doi.org\/10.1007\/s12012-023-09784-8","journal-title":"Cardiovascular Toxicology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10126-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10126-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10126-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:24:14Z","timestamp":1782843854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-026-10126-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":93,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10126"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10126-7","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"All experimental procedures were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee of Tokyo University of Agriculture and Technology (Approval No. R07-91).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"61"}}